Chemokine receptor antagonists and methods of use
US9663537B2 · kind B2 · utility
0Cited by
53References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 10, 2015 |
| Grant date | May 30, 2017 |
| Priority date | — |
| Expiry date | Mar 10, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by:or physiologically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.